Health Canada inspection
Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company): Health Canada inspection of Jul 20, 2020
Health Canada · GMP · rating C
Key facts
| Establishment | Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company) |
|---|---|
| City | Brampton |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Jun 18, 2020 |
| End date | Jul 20, 2020 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101281 |
At a glance
- 10–99 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.